Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

CAMP vs AMBA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AMBA Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

AMBA Overall Winner 6-Pillar Tally: CAMP 1 – 5 AMBA Matrix Metrics: CAMP 3 – 7 AMBA

As of Nov 17, 2026, Ambarella, Inc. (AMBA) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CAMP carries a Unified Composite Score of 41.9/100 (SELL) at $3.95 (N/M Forward P/E, -991.8% operating margin), whereas AMBA carries 47.3/100 (HOLD) at $53.72 (82.1x Forward P/E, -14.9% operating margin).

  • Growth vs. Quality Trade-Off: AMBA earns the overall head-to-head edge with a stronger Unified Composite Score (47.3/100 HOLD vs. CAMP 41.9/100 SELL) and 2.60β · 63% Vol risk profile, whereas CAMP leads top-line expansion (+138.9% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 53.3); meanwhile AMBA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CAMP vs AMBA
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$3.95
+2.33% 1D
Market Cap $238.5M
TTM Revenue $5.3M
Forward P/E N/M
Beta / 30D Vol 1.34β · 94% Vol
Unified Composite Score
41.9 / 100 SELL
Tech 30.0 Fund 40.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 53.3 · SMA20: $3.82 · SMA50: $3.84
AMBA NASDAQ Head-to-Head Winner
Ambarella, Inc. Ordinary Shares
Semiconductors & Related Devices
$53.72
-2.38% 1D
Market Cap $2.7B
TTM Revenue $418M
Forward P/E 82.1x
Beta / 30D Vol 2.60β · 63% Vol
Unified Composite Score
47.3 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 73.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.2%), weak momentum, RSI 35
RSI-14: 34.8 · SMA20: $61.82 · SMA50: $64.61

6-Pillar Scorecard Institutional Category Breakdown (CAMP 1 – 5 AMBA)

Columns: Metric · CAMP · AMBA
1. Valuation Multiples AMBA
Forward P/E N/M 82.1x
Trailing P/E N/M 57.1x
PEG Ratio N/M 4.97x
EV / Revenue 26.6x 6.1x
2. Growth & Scale AMBA
Revenue Growth (YoY) +138.9% +13.2%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $5.3M $418M
Market Cap $238.5M $2.7B
3. Profitability & Quality AMBA
Gross Margin N/A 58.5%
Operating Margin -991.8% -14.9%
Net Profit Margin 0.0% -13.5%
Return on Equity (ROE) -146.1% -9.4%
4. Balance Sheet & Cash Flow AMBA
Cash Generation (TTM) -$26M $9.7M
Cash Flow Margin N/A 2.3%
Net Cash / Leverage $97M Net Cash $89M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CAMP
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 92.4% (16th %ile)
Put/Call OI Skew N/A 1.25x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat AMBA
OpEx & R&D Intensity N/A 73.4% of Rev ($307M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Semiconductor Equipment & Materials Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CAMP (3) vs AMBA (7)
Institutional Metric CAMP AMBA Criterion Row Edge
Market Capitalization
Scale
$238.5M $2.7B Larger Scale AMBA
Trailing P/E Ratio
Valuation
N/M 57.1x Lower Multiple AMBA
Forward P/E Ratio
Valuation
N/M 82.1x Lower Multiple AMBA
Revenue Growth (YoY)
Growth
+138.9% +13.2% Higher Growth CAMP
Operating Margin (TTM)
Profitability
-991.8% -14.9% Higher Margin AMBA
Net Profit Margin
Profitability
0.0% -13.5% Higher Margin CAMP
Return on Equity (ROE)
Capital Efficiency
-146.1% -9.4% Higher ROE AMBA
52-Week Range Position
Momentum
22% ($3–$8) 11% ($48–$96) Stronger Trend CAMP
Beta / 30D Volatility
Risk Regime
1.34β · 94% Vol 2.60β · 63% Vol Lower Realized Risk AMBA
Unified Institutional Score
Composite Signal
41.9 / 100 (SELL) 47.3 / 100 (HOLD) Higher Composite AMBA
Trailing 12M Revenue (USD)
Operating Scale
$5.3M $418M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 58.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 26.6x EV/Rev 4.97x PEG · 6.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$26M ($97M Net Cash) $9.7M ($89M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CAMP +40.2 pp
CAMP: +25.8% · AMBA: -14.4%
3M Horizon CAMP +12.93 pp
CAMP: -15.05% · AMBA: -27.98%
6M Horizon CAMP +25.13 pp
CAMP: -4.82% · AMBA: -29.95%
1Y Horizon CAMP +35.18 pp
CAMP: -3.66% · AMBA: -38.84%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CAMP Revenue AMBA Revenue CAMP Op. Margin AMBA Op. Margin Margin Leader
FY2019 N/A $230M N/A -17.7% AMBA
FY2020 N/A $230M N/A -21.7% AMBA
FY2021 N/A $220M N/A -27.4% AMBA
FY2022 N/A $330M N/A -8.9% AMBA
FY2023 $0M $340M -14822.6% -22.0% AMBA
FY2024 $0M $230M -8142.3% -68.2% AMBA
FY2025 $0M $280M -1502.4% -44.4% AMBA
FY2026 N/A $390M N/A -21.1% AMBA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CAMP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CAMP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AMBA BREAKDOWN
122d in phase · OBV DISTRIBUTION
Current IV 92.4%
IV Percentile 16th %ile
Put/Call OI Skew 1.25x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact AMBA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $55.03 · IV 90.5%

AMBA Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($5,503)

Compare $5,503 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 90.5% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $60 / $67.5 Bull Call Spread

Buy 1x $60C · Sell 1x $67.5C · 32d

Net Entry $63 Debit
T+5d @ +5% Move +$42 (+66%)
Max Risk / Buffer $63 Capped
5d Edge & Liquidity 2.0x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Dec 18 $50 / $45 Bull Put Spread

Sell 1x $50P · Buy 1x $45P · 32d

Net Entry $80 Credit
Max Credit / Yield +$80 (+19.0% RoM)
Max Risk / Buffer -10.6% Cushion ($420 Mgn)
5d Edge & Liquidity 72% PoP · Liq C
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq B

Dec 18 $60 / $50 Bear Put Spread

Buy 1x $60P · Sell 1x $50P · 32d

Net Entry $580 Debit
T+5d @ -5% Drop +$85 (+15%)
Max Risk / Buffer $580 Capped
5d Edge & Liquidity 0.7x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CAMP Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $238.5M market capitalization and -991.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AMBA Moat Profile Cyclical / Execution-Driven Positioning
Semiconductor Equipment & Materials Operator
Competes within the Semiconductor Equipment & Materials value chain with $2.7B market capitalization and -14.9% operating margin.
OpEx & R&D Reinvestment 73.4% of Rev ($307M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (16 partners):
Taiwan Semiconductor Manufacturing Company ASE Technology Holding Amkor Technology Synopsys

Investor FAQ CAMP vs AMBA Key Questions & Quantitative Answers

As of Nov 17, 2026, Ambarella, Inc. (AMBA) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CAMP carries a Unified Composite Score of 41.9/100 (SELL) at $3.95 (N/M Forward P/E, -991.8% operating margin), whereas AMBA carries 47.3/100 (HOLD) at $53.72 (82.1x Forward P/E, -14.9% operating margin). Growth vs. Quality Trade-Off: AMBA earns the overall head-to-head edge with a stronger Unified Composite Score (47.3/100 HOLD vs. CAMP 41.9/100 SELL) and 2.60β · 63% Vol risk profile, whereas CAMP leads top-line expansion (+138.9% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 53.3); meanwhile AMBA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AMBA leads the Growth & Scale pillar: CAMP posts +138.9% YoY revenue growth and +0.0% YoY earnings growth on $5.3M TTM revenue (N/A gross margin, -991.8% operating margin), compared with AMBA at +13.2% YoY revenue growth and +0.0% YoY earnings growth on $418M TTM revenue (58.5% gross margin, -14.9% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), CAMP cumulative revenue shifted N/A while AMBA shifted +69.6%. In operating R&D and SG&A reinvestment, CAMP deploys N/A (0 90-day corporate R&D disclosures) versus 73.4% of Rev ($307M) (0 disclosures) for AMBA.

AMBA screens cheaper on headline valuation multiples. CAMP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 26.6x EV/Revenue (unreported FCF margin), whereas AMBA trades at 82.1x Forward P/E, 57.1x Trailing P/E, 4.97x PEG, and 6.1x EV/Revenue (2.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CAMP (-146.1% ROE) versus AMBA (-9.4% ROE) capital efficiency.

In options market volatility and institutional positioning, CAMP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.34β · 94% Vol realized risk). By comparison, AMBA carries 92.4% implied volatility (16th %ile, Compressed (<25th %ile)), a 1.25x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.60β · 63% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.